Vigil
Vigil is a Massachusetts-based biotechnology company that develops and commercializes microglia-based therapeutics for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Vigil Information
Geographic Data
Address: 300 Technology Square
City: Cambridge
State: MA
Zip: 02139
Country: US
Financial Info
Stage:
series b
Raised Last:
$90M
Raised Total:$161M
Social
Metrics
3,066,312Website Global Rank
5,570Website Monthly Traffic
Twitter Followers
Description
Vigil is a Massachusetts-based biotechnology company that develops and commercializes microglia-based therapeutics for the treatment of neurodegenerative diseases.
Contact Phone:
+18572544445
Contact Email:
Vigil went public on 1/7/2022 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/7/2022
IPO Valuation:
$396M
Ticker Symbol:
VIGL
IPO Price:
$14/share
Amount Raised:
$98M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
